Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Antazoline in Rapid Cardioversion of Paroxysmal Atrial Fibrillation (AnPAF)

This study has been completed.
Information provided by (Responsible Party):
Institute of Cardiology, Warsaw, Poland Identifier:
First received: February 2, 2012
Last updated: May 21, 2015
Last verified: May 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2015
  Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)